BD Biosciences

News, research and analysis about Becton Dickinson Biosciences, an American medical technology company that manufactures and sells medical devices, instrument systems and reagents.

January 12, 2016

Evolution M&A Analysis: Thermo Fisher to Acquire Affymetrix for $1.3 billion

Thermo Fisher Scientific (NYSE:TMO) have announced an agreement to acquire Affymetrix (NASDAQ:AFFX) for approximately $1.3 billion, or $14.00 per share, in cash. The acquisition was unanimously […]
October 28, 2014

BD Biosciences Announce Multiple Acquisitions

BD To Acquire CareFusion For $12.2 Billion BD and CareFusion announced a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash […]